Scientists at Oregon State University have filed a patent on a design for a new magnetic resonance imaging contrast agent ...

Fenebrutinib met primary goals in two late-stage trials for the treatment of two different forms of multiple sclerosis.

Roche said on Monday that a late-stage trial testing its multiple sclerosis drug candidate fenebrutinib against the relapsing form of the disease achieved its primary goal.

Researcher Melissa Schilling said that she was "surprised to find such a strong geographic pattern" in the U.S. distribution ...

Veralux, the state’s first dedicated whole-body MRI center, is set to open this month in the Pinnacle Hills area of Rogers.

Scientists at Oregon State University have filed a patent on a design for a new magnetic resonance imaging contrast agent ...

It started with exhaustion. Not the kind that goes away with a nap or a night of decent sleep, but the kind that seeps into your bones and makes even breathing feel heavy.

A new AI-assisted brain atlas that can help visualise the human brain in unprecedented detail has been developed by ...

I feel like the ending of my career overshadowed my actual career and who I was. … I just hope that fans can recall the good ...

DelveInsight's Chronic Progressive Multiple Sclerosis Market Insights report includes a comprehensive understanding of current treatment practices, chronic progressive multiple sclerosis emerging ...

A study using wearable scanning technology has revealed how brain function differs in people with multiple sclerosis (MS). It ...